Illumina, Inc. (ILMN) stock
ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3016% above fair value
$207.01−2.54 (-1.21%)
Close on Nov 13, 2026Market cap $31.30BP/E 35.5Yield –
Illumina r&d expenses
Research and development expenses are spending on new products and technology.
Illumina's R&D Expenses for the twelve months ending Sep 27, 2026 was $975.00M, down 0.9% year over year. For fiscal 2025 it was $967.00M, down 17.3% from the year before. Over ten years it grew 9.2% a year on average. The highest annual figure on record is $1.35B in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $967.00M | -17.3% |
| FY2024 | Dec 29, 2024 | $1.17B | -13.7% |
| FY2023 | Dec 31, 2023 | $1.35B | +2.5% |
| FY2022 | Jan 1, 2023 | $1.32B | +11.5% |
| FY2021 | Jan 2, 2022 | $1.19B | +73.8% |
| FY2020 | Jan 3, 2021 | $682.00M | +5.4% |
| FY2019 | Dec 29, 2019 | $647.00M | +3.9% |
| FY2018 | Dec 30, 2018 | $623.00M | +14.1% |
| FY2017 | Dec 31, 2017 | $546.00M | +8.3% |
| FY2016 | Jan 1, 2017 | $504.00M | +25.7% |
| FY2015 | Jan 3, 2016 | $401.00M | +3.3% |
| FY2014 | Dec 28, 2014 | $388.06M | +40.2% |
| FY2013 | Dec 29, 2013 | $276.74M | +19.8% |
| FY2012 | Dec 30, 2012 | $231.03M | +17.3% |
| FY2011 | Jan 1, 2012 | $196.91M | +10.7% |
| FY2010 | Jan 2, 2011 | $177.95M | +26.5% |
| FY2009 | Jan 3, 2010 | $140.62M | +40.7% |
| FY2008 | Dec 28, 2008 | $99.96M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | $244.00M | +6.6% |
| Q2 FY2026 | Jun 28, 2026 | $252.00M | +2.0% |
| Q1 FY2026 | Mar 29, 2026 | $240.00M | -4.8% |
| Q4 FY2025 | Dec 28, 2025 | $239.00M | -6.6% |
| Q3 FY2025 | Sep 28, 2025 | $229.00M | -9.5% |
| Q2 FY2025 | Jun 29, 2025 | $247.00M | -24.0% |
| Q1 FY2025 | Mar 30, 2025 | $252.00M | -25.7% |
| Q4 FY2024 | Dec 29, 2024 | $256.00M | -24.9% |
| Q3 FY2024 | Sep 29, 2024 | $253.00M | -19.7% |
| Q2 FY2024 | Jun 30, 2024 | $325.00M | -9.2% |
| Q1 FY2024 | Mar 31, 2024 | $339.00M | -0.6% |
| Q4 FY2023 | Dec 31, 2023 | $341.00M | -1.4% |
| Q3 FY2023 | Oct 1, 2023 | $315.00M | -3.1% |
| Q2 FY2023 | Jul 2, 2023 | $358.00M | +9.5% |
| Q1 FY2023 | Apr 2, 2023 | $341.00M | +5.6% |
| Q4 FY2022 | Jan 1, 2023 | $346.00M | -1.1% |
| Q3 FY2022 | Oct 2, 2022 | $325.00M | -25.5% |
| Q2 FY2022 | Jul 3, 2022 | $327.00M | +61.9% |
| Q1 FY2022 | Apr 3, 2022 | $323.00M | +64.0% |
| Q4 FY2021 | Jan 2, 2022 | $350.00M | +75.9% |
| Q3 FY2021 | Oct 3, 2021 | $436.00M | +153.5% |
| Q2 FY2021 | Jul 4, 2021 | $202.00M | +30.3% |
| Q1 FY2021 | Apr 4, 2021 | $197.00M | +26.3% |
| Q4 FY2020 | Jan 3, 2021 | $199.00M | +23.6% |
| Q3 FY2020 | Sep 27, 2020 | $172.00M | +13.9% |
| Q2 FY2020 | Jun 28, 2020 | $155.00M | -6.6% |
| Q1 FY2020 | Mar 29, 2020 | $156.00M | -7.7% |
| Q4 FY2019 | Dec 29, 2019 | $161.00M | -8.5% |
| Q3 FY2019 | Sep 29, 2019 | $151.00M | -5.0% |
| Q2 FY2019 | Jun 30, 2019 | $166.00M | +9.9% |
| Q1 FY2019 | Mar 31, 2019 | $169.00M | +23.4% |
| Q4 FY2018 | Dec 30, 2018 | $176.00M | +28.5% |
| Q3 FY2018 | Sep 30, 2018 | $159.00M | +18.7% |
| Q2 FY2018 | Jul 1, 2018 | $151.00M | +16.2% |
| Q1 FY2018 | Apr 1, 2018 | $137.00M | -5.5% |
| Q4 FY2017 | Dec 31, 2017 | $137.00M | +5.4% |
| Q3 FY2017 | Oct 1, 2017 | $134.00M | – |
| Q2 FY2017 | Jul 2, 2017 | $130.00M | – |
| Q1 FY2017 | Apr 2, 2017 | $145.00M | – |
| Q4 FY2016 | Jan 1, 2017 | $130.00M | – |
See a number that looks wrong?